何 中良

研究成果

每年研究成果 1995 2005 2006 2010 2013 2019 2024

• 78 Article
• 4 Review article
• 4 Patent
• 3 Letter
• 2 更多
  • 1 Conference contribution
  • 1 Comment/debate

每年研究成果

每年研究成果

搜尋結果

• 2024

  A pilot study on the detection of microsatellite instability using long mononucleotide repeats in solid tumors

  Liu, T., Ho, C. L., Chen, Y. J., Chen, P. J., Chen, W. L., Lee, C. T., Chow, N. H., Huang, W. & Chen, Y. L., 2024 9月, 於: Oncology Letters. 28, 3, 445.

  研究成果: Article › 同行評審

  開啟存取
• 2023

  A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma

  Tsai, H. W., Cheng, S. W., Chen, C. C., Chen, I. W. & Ho, C. L., 2023 12月, 於: BMC cancer. 23, 1, 1025.

  研究成果: Article › 同行評審

  開啟存取

  • Catenins 100%
  • Computational Biology 74%
  • Hepatocellular Carcinoma 63%
  • Wnt Signaling Pathway 44%
  • TCF Transcription Factors 40%
  2 引文 斯高帕斯（Scopus）

• Clinical implications of PNA-sequencing as a complementary test for EGFR mutation analysis in human lung cancer

  Chen, Y. L., Lin, C. C., Yu, Y. T., Chen, W. L., Yang, S. C., Huang, W., Su, W. C., Chow, N. H. & Ho, C. L., 2023, 於: Oncology Letters. 26, 6, 539.

  研究成果: Article › 同行評審

  開啟存取

  • Peptide Nucleic Acids 100%
  • Lung Neoplasms 53%
  • Mutation 37%
  • ErbB Receptors 25%
  • Protein-Tyrosine Kinases 24%

• Dual role of sprouty2 as an inhibitor of RAS/ERK-driven proliferation and a promoter of cancer invasion in KRAS wild-type colorectal cancer

  Lee, C. T., Chu, C. A., Wang, Y. M., Wang, Y. W., Chen, Y. L., Ho, C. L., Yeh, Y. M., Lin, P. C., Lin, B. W., Chen, P. C., Chen, S. H., Chan, R. H., Chang, C. & Chow, N. H., 2023 7月, 於: Molecular Carcinogenesis. 62, 7, p. 951-962 12 p.

  研究成果: Article › 同行評審

  • Colorectal Neoplasms 100%
  • Caco-2 Cells 63%
  • Neoplasms 40%
  • Plasmids 29%
  • Cell Proliferation 23%
  2 引文 斯高帕斯（Scopus）

• High concordance rate of capillary electrophoresis workflow for microsatellite instability analysis and mismatch repair (MMR) immunostaining in colorectal carcinoma

  Huang, W., Ho, C. L., Lee, C. T., Chen, W. L., Yang, S. C., Chow, N. H. & Chen, Y. L., 2023 4月, 於: PloS one. 18, 4 April, e0284227.

  研究成果: Article › 同行評審

  開啟存取

  • Capillary Electrophoresis 100%
  • Colorectal Neoplasms 60%
  • Gels 20%
  • Immunotherapy 11%
  • Fluorescence 10%
  1 引文 斯高帕斯（Scopus）
• 2022

  Case report: Salvage capmatinib therapy in KIF5B-MET fusion-positive lung adenocarcinoma with resistance to telisotuzumab vedotin

  Lin, C. Y., Wei, S. H., Chen, Y. L., Lee, C. T., Wu, S. Y., Ho, C. L., Pavlick, D. C., Su, P. L. & Lin, C. C., 2022 8月 11, 於: Frontiers in Oncology. 12, 919123.

  研究成果: Article › 同行評審

  開啟存取

  • capmatinib 100%
  • Adenocarcinoma of Lung 52%
  • Non-Small Cell Lung Carcinoma 43%
  • Drug Therapy 14%
  • Therapeutics 4%
  2 引文 斯高帕斯（Scopus）

• Enhancing diagnosis of T-cell lymphoma using non-recombined T-cell receptor sequences

  Chen, Y. L., Ho, C. L., Hung, C. Y., Chen, W. L., Chang, C., Hou, Y. H., Chen, J. R., Chen, P. J., Chow, N. H., Huang, W., Hsu, Y. T., Chen, T. Y. & Liu, T., 2022 12月 8, 於: Frontiers in Oncology. 12, 1014132.

  研究成果: Article › 同行評審

  開啟存取

  • T-Cell Lymphoma 100%
  • T-Cell Receptor Genes 25%
  • Negative Results 10%
  • Genetic Background 10%
  • Genetic Variation 9%
  1 引文 斯高帕斯（Scopus）

• Nasal Microbiome Change During and After Exacerbation in Asthmatic Children

  Liu, T., Lin, C. H., Chen, Y. L., Jeng, S. L., Tsai, H. J., Ho, C. L., Kuo, W. S., Hsieh, M. H., Chen, P. C., Wu, L. S. H. & Wang, J. Y., 2022 3月 4, 於: Frontiers in Microbiology. 12, 833726.

  研究成果: Article › 同行評審

  開啟存取

  • Microbiota 100%
  • Nose 81%
  • Asthma 31%
  • Mites 25%
  • Pharynx 20%
  9 引文 斯高帕斯（Scopus）

• The impact of driver mutation on the treatment outcome of early-stage lung cancer patients receiving neoadjuvant immunotherapy and chemotherapy

  Su, P. L., Chen, J. Y., Chu, C. Y., Chen, Y. L., Chen, W. L., Lin, K. Y., Ho, C. L., Tsai, J. S., Yang, S. C., Chen, C. W., Wu, Y. L., Tseng, Y. L., Chang, C. C., Yen, Y. T., Lin, C. Y., Lin, C. C. & Su, W. C., 2022 12月, 於: Scientific reports. 12, 1, 3319.

  研究成果: Article › 同行評審

  開啟存取

  • Immunotherapy 100%
  • Lung Neoplasms 89%
  • Drug Therapy 66%
  • Mutation 63%
  • Neoadjuvant Therapy 39%
  9 引文 斯高帕斯（Scopus）
• 2021

  Clinicopathological features of mismatch repair protein expression patterns in colorectal cancer

  Lee, C. T., Chow, N. H., Chen, Y. L., Ho, C. L., Yeh, Y. M., Lin, S. C., Lin, P. C., Lin, B. W., Chu, C. A., Tsai, H. W. & Lee, J. C., 2021 1月, 於: Pathology Research and Practice. 217, 153288.

  研究成果: Article › 同行評審

  開啟存取

  • Colorectal Neoplasms 66%
  • Proteins 30%
  • Mutation 12%
  • Immunohistochemistry 7%
  • Hereditary Nonpolyposis Colorectal Neoplasms 7%
  11 引文 斯高帕斯（Scopus）

• Development of a novel ALK rearrangement screening test for non-small cell lung cancers

  Chen, Y. L., Chen, W. L., Cheng, Y. C., Lin, M. C., Yang, S. C., Tsai, H. W., Lin, C. C., Su, W. C., Chow, N. H. & Ho, C. L., 2021 9月, 於: PloS one. 16, 9 September, e0257152.

  研究成果: Article › 同行評審

  開啟存取

  • Non-Small Cell Lung Carcinoma 67%
  • Malignant Pleural Effusion 27%
  • Formaldehyde 18%
  • Paraffin 18%
  • Reverse Transcription 13%
  3 引文 斯高帕斯（Scopus）

• Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features

  Cheng, H. L., Chou, L. P., Tsai, H. W., Lee, C. T., Wang, Y. W., Chung-Liang, H., Ou, J. H., Tsai, Y. S. & Chow, N. H., 2021 10月, 於: Urologic Oncology: Seminars and Original Investigations. 39, 10, p. 732.e17-732.e23

  研究成果: Article › 同行評審

  • Urinary Bladder 100%
  • Carcinoma 82%
  • Urinary Tract 50%
  • Urologic Neoplasms 35%
  • Statistical Models 28%
  6 引文 斯高帕斯（Scopus）
• 2020

  Electric Field–Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva

  Tu, M., Cheng, J., Chen, Y. L., Jea, W. C., Chen, W. L., Chen, C. J., Ho, C. L., Huang, W. L., Lin, C. C., Su, W. C., Ye, Q., Deignan, J., Grody, W., Li, F., Chia, D., Wei, F., Liao, W., Wong, D. T. W. & Strom, C. M., 2020 8月, 於: Journal of Molecular Diagnostics. 22, 8, p. 1050-1062 13 p.

  研究成果: Article › 同行評審

  • Liquid Biopsy 100%
  • Limit of Detection 75%
  • Saliva 69%
  • Single-Stranded DNA 57%
  • Mutation 26%
  17 引文 斯高帕斯（Scopus）
• 2019

  Clinical Evaluation of IntelliPlex™ KRAS G12/13 Mutation Kit for Detection of KRAS Mutations in Codon 12 and 13: A Novel Multiplex Approach

  Chen, C. L., Chen, C. K., Ho, C. L., Chi, W. M., Yeh, C. H., Hu, S. P., Friebe, P., Palmer, S. & Huang, C. S., 2019 10月 1, 於: Molecular Diagnosis and Therapy. 23, 5, p. 645-656 12 p.

  研究成果: Article › 同行評審

  • Codon 100%
  • Mutation 56%
  • Colorectal Neoplasms 26%
  • Sensitivity and Specificity 16%
  • Confidence Intervals 13%
  7 引文 斯高帕斯（Scopus）

• Five Technologies for Detecting the EGFR T790M Mutation in the Circulating Cell-Free DNA of Patients With Non-small Cell Lung Cancer: A Comparison

  Chen, Y., Lin, C., Yang, S., Chen, W., Chen, J., Hou, Y., Lu, C., Chow, N., Su, W. & Ho, C., 2019 7月 16, 於: Frontiers in Oncology. 9, p. 631

  研究成果: Article › 同行評審

• Liquid biopsy for detection of EGFR T790M mutation in nonsmall cell lung cancer: An experience of proficiency testing in Taiwan

  Ho, H. L., Huang, C. C., Ku, W. H., Ho, C. L., Lin, C. H., Yu, S. L. & Chou, T. Y., 2019, 於: Journal of the Chinese Medical Association. 82, 6, p. 473-476 4 p.

  研究成果: Article › 同行評審

  • Liquid Biopsy 100%
  • ErbB Receptors 68%
  • Non-Small Cell Lung Carcinoma 63%
  • Cell-Free Nucleic Acids 45%
  • Mutation 40%
  7 引文 斯高帕斯（Scopus）

• Real-world outcomes of NSCLC patients receiving tissue or circulating tumor DNA-guided osimertinib treatment

  Su, P. L., Yang, S. C., Chen, Y. L., Wu, Y. L., Lin, C. Y., Chang, W. Y., Tseng, Y. L., Lai, W. W., Ho, C. L., Lin, C. C. & Su, W. C., 2019 10月 1, 於: Cancer medicine. 8, 13, p. 5939-5947 9 p.

  研究成果: Article › 同行評審

  開啟存取

  • osimertinib 100%
  • Mutation 21%
  • Liquid Biopsy 17%
  • Therapeutics 10%
  • Survival Rate 9%
  12 引文 斯高帕斯（Scopus）
• 2018

  Preventing and treating brain metastases with three first-line EGFR-tyrosine kinase inhibitors in patients with EGFR mutation-positive advanced non-small cell lung cancer

  Su, P. L., Wu, Y. L., Chang, W. Y., Ho, C. L., Tseng, Y. L., Lai, W. W., Su, W. C., Lin, C. C. & Yang, S. C., 2018 1月 1, 於: Therapeutic Advances in Medical Oncology. 10

  研究成果: Article › 同行評審

  開啟存取

  • Protein-Tyrosine Kinases 100%
  • Non-Small Cell Lung Carcinoma 98%
  • Afatinib 76%
  • Gefitinib 62%
  • Mutation 61%
  41 引文 斯高帕斯（Scopus）

• Progesterone receptor membrane component 1 as a potential prognostic biomarker for hepatocellular carcinoma

  Tsai, H. W., Ho, C. L., Cheng, S. W., Lin, Y. J., Chen, C. C., Cheng, P. N., Yen, C. J., Chang, T. T., Chiang, P. M., Chan, S. H., Ho, C. H., Chen, S. H., Wang, Y. W., Chow, N. H. & Lin, J. C., 2018 3月 14, 於: World journal of gastroenterology. 24, 10, p. 1152-1166 15 p.

  研究成果: Article › 同行評審

  開啟存取

  • Progesterone Receptors 100%
  • Hepatocellular Carcinoma 76%
  • Biomarkers 61%
  • Membranes 56%
  • Atlases 14%
  25 引文 斯高帕斯（Scopus）
• 2017

  Liquid biopsy genotyping in lung cancer: Ready for clinical utility?

  Huang, W. L., Chen, Y. L., Yang, S. C., Ho, C. L., Wei, F., Wong, D. T., Su, W. C. & Lin, C. C., 2017, 於: Oncotarget. 8, 11, p. 18590-18608 19 p.

  研究成果: Article › 同行評審

  開啟存取

  • Liquid Biopsy 100%
  • ErbB Receptors 68%
  • Lung Neoplasms 56%
  • DNA 19%
  • Hematologic Tests 18%
  47 引文 斯高帕斯（Scopus）

• Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival

  Lee, C. T., Huang, Y. C., Hung, L. Y., Chow, N. H., Su, P. F., Ho, C. L., Tsai, H. W., Chen, Y. L., Lin, S. C., Lin, B. W., Lin, P. C. & Lee, J. C., 2017, 於: Oncotarget. 8, 21, p. 35165-35175 11 p.

  研究成果: Article › 同行評審

  開啟存取

  • Mucinous Adenocarcinoma 100%
  • Adenocarcinoma 61%
  • CpG Islands 47%
  • Survival 43%
  • Phenotype 23%
  15 引文 斯高帕斯（Scopus）

• StemTextSearch: Stem cell gene database with evidence from abstracts

  Chen, C. C. & Ho, C. L., 2017 5月 1, 於: Journal of Biomedical Informatics. 69, p. 150-159 10 p.

  研究成果: Article › 同行評審

  開啟存取

  • Stem cells 100%
  • Genes 67%
  • Stem Cells 52%
  • Databases 42%
  • Text mining 27%
  2 引文 斯高帕斯（Scopus）
• 2016

  Epidermal growth factor receptor mutation and anaplastic lymphoma kinase gene fusion: Detection in malignant pleural effusion by RNA or PNA analysis

  Chen, Y. L., Lee, C. T., Lu, C. C., Yang, S. C., Chen, W. L., Lee, Y. C., Yang, C. H., Peng, S. L., Su, W. C., Chow, N. H. & Ho, C. L., 2016 6月, 於: PloS one. 11, 6, e0158125.

  研究成果: Article › 同行評審

  開啟存取

  • Malignant Pleural Effusion 100%
  • epidermal growth factor receptors 97%
  • gene fusion 86%
  • lymphoma 85%
  • Gene Fusion 82%
  16 引文 斯高帕斯（Scopus）

• TRIg: A robust alignment pipeline for non-regular T-cell receptor and immunoglobulin sequences

  Hung, S. J., Chen, Y. L., Chu, C. H., Lee, C. C., Chen, W. L., Lin, Y. L., Lin, M. C., Ho, C. L. & Liu, T., 2016 10月 26, 於: BMC Bioinformatics. 17, 1, 433.

  研究成果: Article › 同行評審

  開啟存取

  • T Cell Receptor 100%
  • Immunoglobulin 91%
  • T-cells 84%
  • Recombination 66%
  • Pipeline 65%
  8 引文 斯高帕斯（Scopus）
• 2015

  Obtaining long 16S rDNA sequences using multiple primers and its application on dioxin-containing samples

  Chen, Y. L., Lee, C. C., Lin, Y. L., Yin, K. M., Ho, C. L. & Liu, T., 2015 12月 9, 於: BMC Bioinformatics. 16, 18, S13.

  研究成果: Article › 同行評審

  開啟存取

  • Dioxins 100%
  • Sequencing 89%
  • Ribosomal DNA 87%
  • Pipelines 56%
  • Bacteria 55%
  79 引文 斯高帕斯（Scopus）

• Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer

  Hsu, K. F., Shen, M. R., Huang, Y. F., Cheng, Y. M., Lin, S. H., Chow, N. H., Cheng, S. W., Chou, C. Y. & Ho, C. L., 2015 7月 28, 於: British Journal of Cancer. 113, 3, p. 414-424 11 p.

  研究成果: Article › 同行評審

  開啟存取

  • RNA-Binding Proteins 100%
  • Ovarian Neoplasms 78%
  • Ovarian Epithelial Carcinoma 49%
  • Platinum 30%
  • Copper Transport Proteins 23%
  91 引文 斯高帕斯（Scopus）

• SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor

  Chiang, C. Y., Pan, C. C., Chang, H. Y., Lai, M. D., Tzai, T. S., Tsai, Y. S., Ling, P., Liu, H. S., Lee, B. F., Cheng, H. L., Ho, C. L., Chen, S. H. & Chow, N. H., 2015 12月 15, 於: Clinical Cancer Research. 21, 24, p. 5601-5611 11 p.

  研究成果: Article › 同行評審

  開啟存取

  • src Homology Domains 100%
  • ErbB Receptors 78%
  • Glutamic Acid 72%
  • Carcinoma 54%
  • Biomarkers 53%
  36 引文 斯高帕斯（Scopus）
• 2014

  Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer

  Wei, F., Lin, C. C., Joon, A., Feng, Z., Troche, G., Lira, M. E., Chia, D., Mao, M., Ho, C. L., Su, W. C. & Wong, D. T. W., 2014 11月 15, 於: American Journal of Respiratory and Critical Care Medicine. 190, 10, p. 1117-1126 10 p.

  研究成果: Article › 同行評審

  開啟存取

  • Saliva 74%
  • ErbB Receptors 72%
  • Lung Neoplasms 60%
  • Mutation 42%
  • Non-Small Cell Lung Carcinoma 37%
  142 引文 斯高帕斯（Scopus）

• Verification of wild-type EGFR status in non-small cell lung carcinomas using a mutant-enriched PCR on selected cases

  Chen, Y. L., Lu, C. C., Yang, S. C., Su, W. P., Lin, Y. L., Chen, W. L., Huang, W., Su, W. C., Chow, N. H. & Ho, C. L., 2014 9月, 於: Journal of Molecular Diagnostics. 16, 5, p. 486-494 9 p.

  研究成果: Article › 同行評審

  開啟存取

  • Non-Small Cell Lung Carcinoma 100%
  • locked nucleic acid 86%
  • Peptide Nucleic Acids 82%
  • Cross Reactions 67%
  • Mutation 62%
  14 引文 斯高帕斯（Scopus）
• 2013

  A novel integrated microfluidic platform to perform fluorescence in situ hybridization for chromosomal analysis

  Tai, C. H., Ho, C. L., Chen, Y. L., Chen, W. L. & Lee, G. B., 2013 12月, 於: Microfluidics and Nanofluidics. 15, 6, p. 745-752 8 p.

  研究成果: Article › 同行評審

  • Fluorescence 100%
  • Microfluidics 92%
  • platforms 73%
  • fluorescence 64%
  • abnormalities 57%
  15 引文 斯高帕斯（Scopus）

• Anterior gradient 2: A novel sensitive tumor marker for metastatic oral cancer

  Chen, Y. T., Ho, C. L., Chen, P. K., Chen, Y. L. & Chang, C. F., 2013 10月 10, 於: Cancer Letters. 339, 2, p. 270-278 9 p.

  研究成果: Article › 同行評審

  • Mouth Neoplasms 100%
  • Tumor Biomarkers 89%
  • Biomarkers 39%
  • Genetic Background 32%
  • Gene Expression Profiling 31%
  22 引文 斯高帕斯（Scopus）

• Gastric perforation secondary to regression of lung adenocarcinoma after gefitinib treatment

  Chung, W. P., Song, H. L., Ho, C. L., Chiu, N. T. & Su, W. C., 2013 1月 1, 於: Journal of Clinical Oncology. 31, 1, p. e6-e8

  研究成果: Article › 同行評審
  5 引文 斯高帕斯（Scopus）

• Identification of novel tumor markers for oral squamous cell carcinoma using glycoproteomic analysis

  Chen, Y. T., Chong, Y. M., Cheng, C. W., Ho, C. L., Tsai, H. W., Kasten, F. H., Chen, Y. L. & Chang, C. F., 2013, 於: Clinica Chimica Acta. 420, p. 45-53 9 p.

  研究成果: Article › 同行評審

  • Tumor Marker 100%
  • N-Glycan 95%
  • Tumor Biomarkers 73%
  • Squamous Cell Carcinoma 63%
  • Keratinocytes 26%
  31 引文 斯高帕斯（Scopus）

• Lin28B is an oncofetal circulating cancer stem cell-like marker associated with recurrence of hepatocellular carcinoma

  Cheng, S. W., Tsai, H. W., Lin, Y. J., Cheng, P. N., Chang, Y. C., Yen, C. J., Huang, H. P., Chuang, Y. P., Chang, T. T., Lee, C. T., Chao, A., Chou, C. Y., Chan, S. H., Chow, N. H. & Ho, C. L., 2013 11月 14, 於: PloS one. 8, 11, e80053.

  研究成果: Article › 同行評審

  開啟存取

  • Hepatocellular Carcinoma 75%
  • Blood Cells 30%
  • Expressed Sequence Tags 23%
  • Survival 20%
  • Neoplasm Staging 20%
  51 引文 斯高帕斯（Scopus）
• 2012

  True color blood flow imaging using a high-speed laser photography system

  Liu, C. S., Lin, C. H., Sun, Y. N., Ho, C. L. & Hsu, C. C., 2012 10月, 於: Optical Engineering. 51, 10, 103201.

  研究成果: Article › 同行評審

  • Photography 100%
  • photography 96%
  • blood flow 90%
  • Blood 76%
  • Imaging techniques 63%
  5 引文 斯高帕斯（Scopus）
• 2011

  Germ cell tumor with somatic-type malignancy presenting as right facial swelling in a young woman

  Yu, C-H., Yang, S-C., Lai, W-W., Liao, Y. C., Ho, C-L., Su, W-C. & Chang, H. Y., 2011 8月 20, 於: Journal of Clinical Oncology. 29, 24

  研究成果: Article › 同行評審

• Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach

  Hsu, C. C., Chiang, C. W., Cheng, H. C., Chang, W. T., Chou, C. Y., Tsai, H. W., Lee, C. T., Wu, Z. H., Lee, T. Y., Chao, A., Chow, N. H. & Ho, C. L., 2011 2月 10, 於: Oncogene. 30, 6, p. 654-667 14 p.

  研究成果: Article › 同行評審

  • Oncogenes 100%
  • Computational Biology 99%
  • Genes 42%
  • Cyclin B1 19%
  • Expressed Sequence Tags 18%
  17 引文 斯高帕斯（Scopus）
• 2010

  An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells

  Liu, H. S., Hsu, P. Y., Lai, M. D., Chang, H. Y., Ho, C. L., Cheng, H. L., Chen, H. T., Lin, Y. J., Wu, T. J., Tzai, T. S. & Chow, N. H., 2010 5月 24, 於: Carcinogenesis. 31, 8, p. 1456-1464 9 p.

  研究成果: Article › 同行評審

  開啟存取

  • rice bran saccharide 100%
  • Receptor Protein-Tyrosine Kinases 62%
  • ErbB Receptors 55%
  • Urinary Bladder Neoplasms 33%
  • Starvation 25%
  45 引文 斯高帕斯（Scopus）

• BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan

  Chen, Y. L., Su, I. J., Cheng, H. Y., Chang, K. C., Lu, C. C., Chow, N. H., Ho, C. L. & Huang, W., 2010 4月, 於: Leukemia and Lymphoma. 51, 4, p. 650-655 6 p.

  研究成果: Article › 同行評審

  • T-Lymphocyte Gene Rearrangement 100%
  • T-Cell Receptor Genes 87%
  • T-Cell Lymphoma 75%
  • B-Cell Lymphoma 68%
  • Immunoglobulins 58%
  35 引文 斯高帕斯（Scopus）

• High percentage of JAK2 exon 12 mutation in asian patients with polycythemia vera

  Yeh, Y. M., Chen, Y. L., Cheng, H. Y., Su, W. C., Chow, N. H., Chen, T. Y. & Ho, C. L., 2010 8月, 於: American Journal of Clinical Pathology. 134, 2, p. 266-270 5 p.

  研究成果: Article › 同行評審

  開啟存取

  • Polycythemia Vera 100%
  • Exons 64%
  • Mutation 43%
  • Incidence 8%
  • Platelet Count 8%
  25 引文 斯高帕斯（Scopus）

• Large B cell lymphoma presenting initially in bone marrow, liver and spleen: An aggressive entity associated frequently with haemophagocytic syndrome

  Yeh, Y. M., Chang, K. C., Chen, Y. P., Kao, L. Y., Tsai, H. P., Ho, C. L., Wang, J. R., Jones, D. & Chen, T. Y., 2010 12月, 於: Histopathology. 57, 6, p. 785-795 11 p.

  研究成果: Article › 同行評審

  • Hemophagocytic Lymphohistiocytosis 100%
  • B-Cell Lymphoma 78%
  • Cytogenetics 74%
  • Spleen 58%
  • Bone Marrow 55%
  31 引文 斯高帕斯（Scopus）

• Rapid isolation and detection of cancer cells by utilizing integrated microfluidic systems

  Lien, K. Y., Chuang, Y. H., Hung, L. Y., Hsu, K. F., Lai, W. W., Ho, C. L., Chou, C. Y. & Lee, G. B., 2010 11月 7, 於: Lab on a Chip. 10, 21, p. 2875-2886 12 p.

  研究成果: Article › 同行評審

  • Microfluidics 100%
  • Cells 80%
  • Incubators 37%
  • Microbeads 32%
  • Nucleic acids 30%
  50 引文 斯高帕斯（Scopus）
• 2009

  Cesarean Section Scar Mimicking Uterine Malignant Neoplasm at Positron Emission Tomography/Computed Tomography

  Cheng, Y. M., Ho, C. L., Chiu, N. T. & Hsu, K. F., 2009 5月, 於: Journal of Minimally Invasive Gynecology. 16, 3, p. 372-374 3 p.

  研究成果: Article › 同行評審

  • Uterine Neoplasms 100%
  • Positron Emission Tomography Computed Tomography 84%
  • Cesarean Section 73%
  • Cicatrix 66%
  • Facilitative Glucose Transport Proteins 44%
  3 引文 斯高帕斯（Scopus）

• Live cell tracking based on cellular state recognition from microscopic images

  Sun, Y. N., Lin, C. H., Kuo, C. C., Ho, C. L. & Lin, C. J., 2009 7月, 於: Journal of Microscopy. 235, 1, p. 94-105 12 p.

  研究成果: Article › 同行評審

  開啟存取

  • Life Cycle Stages 15%
  • Cell Division 13%
  5 引文 斯高帕斯（Scopus）

• The analysis of inconsistencies between cytogenetic annotations and sequence mapping by defining the imprecision zones of cytogenetic banding

  Yen, K. H., Ho, C. L. & Lee, C., 2009, 於: Bioinformatics. 25, 7, p. 845-852 8 p.

  研究成果: Article › 同行評審

  開啟存取

  • Cytogenetics 100%
  • Annotation 97%
  • Imprecision 91%
  • Inconsistency 80%
  • Gene 69%
  1 引文 斯高帕斯（Scopus）
• 2008

  Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder

  Chen, J. C., Ho, C. L., Tsai, H. W., Tzai, T. S., Liu, H. S., Chow, N. H., Yang, W. H. & Cheng, H. L., 2008 11月, 於: Anticancer research. 28, 6 B, p. 4149-4154 6 p.

  研究成果: Article › 同行評審

  • Prostate-Specific Antigen 100%
  • Urinary Bladder 78%
  • Carcinoma 64%
  • Neoplasms 19%
  • Serine Proteases 13%
  13 引文 斯高帕斯（Scopus）

• The distribution of interleukin-19 in healthy and neoplastic tissue

  Hsing, C. H., Li, H. H., Hsu, Y. H., Ho, C. L., Chuang, S. S., Lan, K. M. & Chang, M. S., 2008 11月, 於: Cytokine. 44, 2, p. 221-228 8 p.

  研究成果: Article › 同行評審

  • Interleukins 100%
  • Microarrays 98%
  • Protein 37%
  • Squamous Cell Carcinoma 27%
  • Mouth 14%
  29 引文 斯高帕斯（Scopus）

• The Molecular Signature for Urothelial Carcinoma of the Upper Urinary Tract

  Ho, C. L., Tzai, T. S., Chen, J. C., Tsai, H. W., Cheng, H. L., Eisenberger, C. F. & Chow, N. H., 2008 3月, 於: Journal of Urology. 179, 3, p. 1155-1159 5 p.

  研究成果: Article › 同行評審

  • Urinary Tract 100%
  • Renal Cell Carcinoma 80%
  • Loss of Heterozygosity 76%
  • Carcinoma 66%
  • Urine 59%
  7 引文 斯高帕斯（Scopus）
• 2007

  Erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis: Acute ocular manifestations, causes, and management

  Chang, Y. S., Huang, F. C., Tseng, S. H., Hsu, C. K., Ho, C. L. & Sheu, H. M., 2007 2月, 於: Cornea. 26, 2, p. 123-129 7 p.

  研究成果: Article › 同行評審

  • Erythema Multiforme 100%
  • Stevens-Johnson Syndrome 91%
  • Eye Manifestations 90%
  • Allopurinol 22%
  • Carbamazepine 19%
  153 引文 斯高帕斯（Scopus）
• 2006

  Collaboration of RON and Epidermal Growth Factor Receptor in Human Bladder Carcinogenesis

  Hsu, P. Y., Liu, H. S., Cheng, H. L., Tzai, T. S., Guo, H. R., Ho, C. L. & Chow, N. H., 2006 11月, 於: Journal of Urology. 176, 5, p. 2262-2267 6 p.

  研究成果: Article › 同行評審

  • rice bran saccharide 100%
  • ErbB Receptors 55%
  • Urinary Bladder 46%
  • Carcinogenesis 44%
  • Urinary Bladder Neoplasms 22%
  32 引文 斯高帕斯（Scopus）